Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 224

1.

Effects of bilateral stimulation of the subthalamic nucleus in Parkinson's disease with and without REM sleep behaviour disorder.

Bargiotas P, Debove I, Bargiotas I, Lachenmayer ML, Ntafouli M, Vayatis N, Schüpbach MW, Krack P, Bassetti CL.

J Neurol Neurosurg Psychiatry. 2019 Aug 17. pii: jnnp-2019-320858. doi: 10.1136/jnnp-2019-320858. [Epub ahead of print]

PMID:
31422368
2.

Acute lethargy after abrupt apomorphine withdrawal in Parkinson's disease.

Cavallieri F, Fraix V, Meoni S, Krack P, Moro E, Castrioto A.

J Neurol Sci. 2019 Sep 15;404:44-46. doi: 10.1016/j.jns.2019.07.011. Epub 2019 Jul 10. No abstract available.

PMID:
31325667
3.

Early limbic microstructural alterations in apathy and depression in de novo Parkinson's disease.

Prange S, Metereau E, Maillet A, Lhommée E, Klinger H, Pelissier P, Ibarrola D, Heckemann RA, Castrioto A, Tremblay L, Sgambato V, Broussolle E, Krack P, Thobois S.

Mov Disord. 2019 Jul 15. doi: 10.1002/mds.27793. [Epub ahead of print]

PMID:
31309609
4.

Programming parameters of subthalamic deep brain stimulators in Parkinson's disease from a controlled trial.

Knudsen K, Krack P, Tonder L, Houeto JL, Rau J, Schade-Brittinger C, Hartmann A, Hälbig TD, Paschen S, Barbe MT, Kühn A, Fraix V, Brefel-Courbon C, Vesper J, Maltête D, Sixel-Döring F, Weiss D, Witjas T, Thobois S, Agid Y, Schnitzler A, Schuepbach WMM, Timmermann L, Damier P, Vidailhet M, Deuschl G; EARLYSTIM study group.

Parkinsonism Relat Disord. 2019 Jun 18. pii: S1353-8020(19)30244-5. doi: 10.1016/j.parkreldis.2019.05.023. [Epub ahead of print]

PMID:
31257096
5.

Scales to assess impulsive and compulsive behaviors in Parkinson's disease: Critique and recommendations.

Evans AH, Okai D, Weintraub D, Lim SY, O'Sullivan SS, Voon V, Krack P, Sampaio C, Post B, Leentjens AFG, Martinez-Martin P, Stebbins GT, Goetz CG, Schrag A; Members of the International Parkinson and Movement Disorder Society (IPMDS) Rating Scales Review Committee.

Mov Disord. 2019 Jun;34(6):791-798. doi: 10.1002/mds.27689. Epub 2019 May 28. Review.

PMID:
31136681
6.

Directional stimulation of subthalamic nucleus sweet spot predicts clinical efficacy: Proof of concept.

Nguyen TAK, Nowacki A, Debove I, Petermann K, Tinkhauser G, Wiest R, Schüpbach M, Krack P, Pollo C.

Brain Stimul. 2019 Sep - Oct;12(5):1127-1134. doi: 10.1016/j.brs.2019.05.001. Epub 2019 May 17.

PMID:
31130498
7.

Suicide and suicide attempts after subthalamic nucleus stimulation in Parkinson disease.

Giannini G, Francois M, Lhommée E, Polosan M, Schmitt E, Fraix V, Castrioto A, Ardouin C, Bichon A, Pollak P, Benabid AL, Seigneuret E, Chabardes S, Wack M, Krack P, Moro E.

Neurology. 2019 Jul 2;93(1):e97-e105. doi: 10.1212/WNL.0000000000007665. Epub 2019 May 17.

PMID:
31101738
8.

Shame in Parkinson'S Disease: A Review.

Angulo J, Fleury V, Péron JA, Penzenstadler L, Zullino D, Krack P.

J Parkinsons Dis. 2019;9(3):489-499. doi: 10.3233/JPD-181462.

9.

Author Correction: Biomarkers for closed-loop deep brain stimulation in Parkinson disease and beyond.

Bouthour W, Mégevand P, Donoghue J, Lüscher C, Birbaumer N, Krack P.

Nat Rev Neurol. 2019 Jun;15(6):363. doi: 10.1038/s41582-019-0189-x.

PMID:
30992557
10.

Long-term effects of subthalamic stimulation in Obsessive-Compulsive Disorder: Follow-up of a randomized controlled trial.

Mallet L, Du Montcel ST, Clair AH, Arbus C, Bardinet E, Baup N, Chabardès S, Chéreau I, Czernecki V, Fontaine D, Harika-Germaneau G, Haynes WI, Houeto JL, Jaafari N, Krack P, Millet B, Navarro S, Polosan M, Pelissolo A, Welter ML; STOC Long-term Study Group.

Brain Stimul. 2019 Jul - Aug;12(4):1080-1082. doi: 10.1016/j.brs.2019.04.004. Epub 2019 Apr 9. No abstract available.

PMID:
30992192
11.

Biomarkers for closed-loop deep brain stimulation in Parkinson disease and beyond.

Bouthour W, Mégevand P, Donoghue J, Lüscher C, Birbaumer N, Krack P.

Nat Rev Neurol. 2019 Jun;15(6):343-352. doi: 10.1038/s41582-019-0166-4. Review. Erratum in: Nat Rev Neurol. 2019 Apr 16;:.

PMID:
30936569
12.

Apathy in Parkinson's disease with REM sleep behavior disorder.

Bargiotas P, Ntafouli M, Lachenmayer ML, Krack P, Schüpbach WMM, Bassetti CLA.

J Neurol Sci. 2019 Apr 15;399:194-198. doi: 10.1016/j.jns.2019.02.028. Epub 2019 Feb 20.

PMID:
30826716
13.

Quality of life predicts outcome of deep brain stimulation in early Parkinson disease.

Schuepbach WMM, Tonder L, Schnitzler A, Krack P, Rau J, Hartmann A, Hälbig TD, Pineau F, Falk A, Paschen L, Paschen S, Volkmann J, Dafsari HS, Barbe MT, Fink GR, Kühn A, Kupsch A, Schneider GH, Seigneuret E, Fraix V, Kistner A, Chaynes PP, Ory-Magne F, Brefel-Courbon C, Vesper J, Wojtecki L, Derrey S, Maltête D, Damier P, Derkinderen P, Sixel-Döring F, Trenkwalder C, Gharabaghi A, Wächter T, Weiss D, Pinsker MO, Regis JM, Witjas T, Thobois S, Mertens P, Knudsen K, Schade-Brittinger C, Houeto JL, Agid Y, Vidailhet M, Timmermann L, Deuschl G; EARLYSTIM study group.

Neurology. 2019 Mar 5;92(10):e1109-e1120. doi: 10.1212/WNL.0000000000007037. Epub 2019 Feb 8. Erratum in: Neurology. 2019 Jun 11;92(24):1166.

14.

Affective modulation of the associative-limbic subthalamic nucleus: deep brain stimulation in obsessive-compulsive disorder.

Polosan M, Droux F, Kibleur A, Chabardes S, Bougerol T, David O, Krack P, Voon V.

Transl Psychiatry. 2019 Feb 4;9(1):73. doi: 10.1038/s41398-019-0404-y.

15.

The Pioneering and Unknown Stereotactic Approach of Roeder and Orthner from Göttingen. Part II: Long-Term Outcome and Postmortem Analysis of Bilateral Pallidotomy in the Pre-Levodopa Era.

Hamel W, Köppen JA, Müller D, Hariz M, Moll CKE, Krack P.

Stereotact Funct Neurosurg. 2018;96(6):353-363. doi: 10.1159/000495412. Epub 2019 Jan 16. Review.

16.

Wait and you shall see: sexual delay discounting in hypersexual Parkinson's disease.

Girard R, Obeso I, Thobois S, Park SA, Vidal T, Favre E, Ulla M, Broussolle E, Krack P, Durif F, Dreher JC.

Brain. 2019 Jan 1;142(1):146-162. doi: 10.1093/brain/awy298.

PMID:
30590514
17.

Suggestive association between OPRM1 and impulse control disorders in Parkinson's disease.

Cormier-Dequaire F, Bekadar S, Anheim M, Lebbah S, Pelissolo A, Krack P, Lacomblez L, Lhommée E, Castrioto A, Azulay JP, Defebvre L, Kreisler A, Durif F, Marques-Raquel A, Brefel-Courbon C, Grabli D, Roze E, Llorca PM, Ory-Magne F, Benatru I, Ansquer S, Maltête D, Tir M, Krystkowiak P, Tranchant C, Lagha-Boukbiza O, Lebrun-Vignes B, Mangone G, Vidailhet M, Charbonnier-Beaupel F, Rascol O, Lesage S, Brice A, Tezenas du Montcel S, Corvol JC; BADGE-PD study group.

Mov Disord. 2018 Dec;33(12):1878-1886. doi: 10.1002/mds.27519. Epub 2018 Nov 16.

PMID:
30444952
18.

The Neuropsychiatric Fluctuations Scale for Parkinson's Disease: A Pilot Study.

Schmitt E, Krack P, Castrioto A, Klinger H, Bichon A, Lhommée E, Pelissier P, Fraix V, Thobois S, Moro E, Martinez-Martin P.

Mov Disord Clin Pract. 2018 Mar 23;5(3):265-272. doi: 10.1002/mdc3.12607. eCollection 2018 May-Jun.

19.

Different effects of levodopa and subthalamic stimulation on emotional conflict in Parkinson's disease.

Martínez-Fernández R, Kibleur A, Chabardès S, Fraix V, Castrioto A, Lhommée E, Moro E, Lescoules L, Pelissier P, David O, Krack P.

Hum Brain Mapp. 2018 Dec;39(12):5014-5027. doi: 10.1002/hbm.24341. Epub 2018 Sep 26.

PMID:
30259598
20.

Hyperdopaminergic behavioral spectrum in Parkinson's disease: A review.

Béreau M, Fleury V, Bouthour W, Castrioto A, Lhommée E, Krack P.

Rev Neurol (Paris). 2018 Nov;174(9):653-663. doi: 10.1016/j.neurol.2018.07.005. Epub 2018 Sep 14. Review.

PMID:
30224159
21.

Crime and Parkinson's: The jury is out.

Santens P, De Letter M, Lees AJ, Krack P, van den Heuvel OA, Bloem BR.

Mov Disord. 2018 Jul;33(7):1092-1094. doi: 10.1002/mds.27436. No abstract available.

PMID:
30153392
22.

Interventions to Reduce Over-Utilized Tests and Treatments in Bronchiolitis.

Tyler A, Krack P, Bakel LA, O'Hara K, Scudamore D, Topoz I, Freeman J, Moss A, Allen R, Swanson A, Bajaj L.

Pediatrics. 2018 Jun;141(6). pii: e20170485. doi: 10.1542/peds.2017-0485. Epub 2018 May 11.

23.

[Movement disorders emergencies].

Burkhard PR, Horvath J, Fleury V, Zacharia A, Bally JF, Bereau M, Bouthour W, Lüscher C, Krack P.

Rev Med Suisse. 2018 Apr 25;14(604):888-891. French.

PMID:
29701435
24.

[Advanced Parkinson's disease : indication for complex treatments].

Béreau M, Tomkova E, Zacharia A, Bouthour W, Fleury V, Bally JF, Horvath J, Momjian S, Lüscher C, Burkhard P, Krack P.

Rev Med Suisse. 2018 Apr 25;14(604):875-878. French.

PMID:
29701432
25.

Dissociable Effects of Subthalamic Stimulation in Obsessive Compulsive Disorder on Risky Reward and Loss Prospects.

Voon V, Droux F, Chabardes S, Bougerol T, Kohl S, David O, Krack P, Polosan M.

Neuroscience. 2018 Jul 1;382:105-114. doi: 10.1016/j.neuroscience.2018.03.010. Epub 2018 Mar 17.

PMID:
29559386
26.

Behavioural outcomes of subthalamic stimulation and medical therapy versus medical therapy alone for Parkinson's disease with early motor complications (EARLYSTIM trial): secondary analysis of an open-label randomised trial.

Lhommée E, Wojtecki L, Czernecki V, Witt K, Maier F, Tonder L, Timmermann L, Hälbig TD, Pineau F, Durif F, Witjas T, Pinsker M, Mehdorn M, Sixel-Döring F, Kupsch A, Krüger R, Elben S, Chabardès S, Thobois S, Brefel-Courbon C, Ory-Magne F, Regis JM, Maltête D, Sauvaget A, Rau J, Schnitzler A, Schüpbach M, Schade-Brittinger C, Deuschl G, Houeto JL, Krack P; EARLYSTIM study group.

Lancet Neurol. 2018 Mar;17(3):223-231. doi: 10.1016/S1474-4422(18)30035-8.

PMID:
29452685
27.

Subthalamic stimulation and neuropsychiatric symptoms in Parkinson's disease: results from a long-term follow-up cohort study.

Abbes M, Lhommée E, Thobois S, Klinger H, Schmitt E, Bichon A, Castrioto A, Xie J, Fraix V, Kistner A, Pélissier P, Seigneuret É, Chabardès S, Mertens P, Broussolle E, Moro E, Krack P.

J Neurol Neurosurg Psychiatry. 2018 Aug;89(8):836-843. doi: 10.1136/jnnp-2017-316373. Epub 2018 Feb 7.

PMID:
29436490
28.

Postoperative rehabilitation after deep brain stimulation surgery for movement disorders.

Allert N, Cheeran B, Deuschl G, Barbe MT, Csoti I, Ebke M, Glaser M, Kang JS, Kelm S, Krack P, Kroth J, Jobst U, Leisse M, Oliviero A, Nolte PN, Quick-Weller J, Strothjohann M, Tamás G, Werner M, Muthuraman M, Volkmann J, Fasano A, Groppa S.

Clin Neurophysiol. 2018 Mar;129(3):592-601. doi: 10.1016/j.clinph.2017.12.035. Epub 2018 Jan 10. Review.

PMID:
29414403
29.

[Obsessive compulsive disorder and deep brain stimulation, a future so close].

Flores Alves Dos Santos J, Krack P, Momjian S, Bondolfi G, Mallet L.

Rev Med Suisse. 2018 Feb 7;14(593):327-330. French.

PMID:
29412526
30.

Historical crossroads in the conceptual delineation of apathy in Parkinson's disease.

Prange S, Pagonabarraga J, Krack P, Kulisevsky J, Sgambato V, Tremblay L, Thobois S, Broussolle E.

Brain. 2018 Feb 1;141(2):613-619. doi: 10.1093/brain/awx362. No abstract available.

PMID:
29329378
31.

Apathy in idiopathic normal pressure hydrocephalus: A marker of reversible gait disorders.

Allali G, Laidet M, Armand S, Saj A, Krack P, Assal F.

Int J Geriatr Psychiatry. 2018 May;33(5):735-742. doi: 10.1002/gps.4847. Epub 2018 Jan 2.

PMID:
29292530
32.

Short pulse width in subthalamic stimulation in Parkinson's disease: a randomized, double-blind study.

Bouthour W, Wegrzyk J, Momjian S, Péron J, Fleury V, Tomkova Chaoui E, Horvath J, Boëx C, Lüscher C, Burkhard PR, Krack P, Zacharia A.

Mov Disord. 2018 Jan;33(1):169-173. doi: 10.1002/mds.27265. Epub 2017 Dec 21.

PMID:
29266392
33.

Reversing dopaminergic sensitization.

Castrioto A, Carnicella S, Fraix V, Chabardes S, Moro E, Krack P.

Mov Disord. 2017 Dec;32(12):1679-1683. doi: 10.1002/mds.27213. Epub 2017 Nov 18. Review. No abstract available.

PMID:
29150871
34.

Pallidal deep brain stimulation for dystonia: a long term study.

Meoni S, Fraix V, Castrioto A, Benabid AL, Seigneuret E, Vercueil L, Pollak P, Krack P, Chevrier E, Chabardes S, Moro E.

J Neurol Neurosurg Psychiatry. 2017 Nov;88(11):960-967. doi: 10.1136/jnnp-2016-315504. Epub 2017 Sep 28.

PMID:
28972096
35.

Thalamic deep brain stimulation for tremor in Parkinson disease, essential tremor, and dystonia.

Cury RG, Fraix V, Castrioto A, Pérez Fernández MA, Krack P, Chabardes S, Seigneuret E, Alho EJL, Benabid AL, Moro E.

Neurology. 2017 Sep 26;89(13):1416-1423. doi: 10.1212/WNL.0000000000004295. Epub 2017 Aug 2.

PMID:
28768840
36.

Psychostimulant effect of dopaminergic treatment and addictions in Parkinson's disease.

Delpont B, Lhommée E, Klinger H, Schmitt E, Bichon A, Fraix V, Castrioto A, Quesada JL, Pélissier P, Kistner A, Carnicella S, Lüscher C, Broussolle E, Pollak P, Thobois S, Krack P.

Mov Disord. 2017 Nov;32(11):1566-1573. doi: 10.1002/mds.27101. Epub 2017 Jul 24.

PMID:
28737225
37.

A deeply superficial brain stimulation.

Bouthour W, Krack P, Lüscher C.

Mov Disord. 2017 Sep;32(9):1326. doi: 10.1002/mds.27111. Epub 2017 Jul 22. No abstract available.

PMID:
28734052
38.

Personality, dopamine, and Parkinson's disease: Insights from subthalamic stimulation.

Lhommée E, Boyer F, Wack M, Pélissier P, Klinger H, Schmitt E, Bichon A, Fraix V, Chabardès S, Mertens P, Castrioto A, Kistner A, Broussolle E, Thobois S, Krack P.

Mov Disord. 2017 Aug;32(8):1191-1200. doi: 10.1002/mds.27065. Epub 2017 Jun 23.

PMID:
28643887
39.

To lesion or not to lesion: That was the question (Reply to "stereotactic ablative surgery does not just mean 'adding another lesion'").

Obeso JA, Martinez-Fernandez R, Del Álamo M, Krack P.

Mov Disord. 2017 Jul;32(7):1113-1114. doi: 10.1002/mds.27066. Epub 2017 Jun 14. No abstract available.

PMID:
28612948
40.

Author response: Long-term improvement in obsessions and compulsions with subthalamic stimulation.

Krack P, Polosan M, Chabardès S, Bougerol T, Ardouin C, Pollak P, Benabid AL.

Neurology. 2017 Apr 25;88(17):1684. doi: 10.1212/WNL.0000000000003878. No abstract available.

PMID:
28438846
41.

Current applications and limitations of surgical treatments for movement disorders.

Krack P, Martinez-Fernandez R, Del Alamo M, Obeso JA.

Mov Disord. 2017 Jan;32(1):36-52. doi: 10.1002/mds.26890. Review.

PMID:
28124435
42.

Decisional impulsivity and the associative-limbic subthalamic nucleus in obsessive-compulsive disorder: stimulation and connectivity.

Voon V, Droux F, Morris L, Chabardes S, Bougerol T, David O, Krack P, Polosan M.

Brain. 2017 Feb;140(2):442-456. doi: 10.1093/brain/aww309. Epub 2016 Dec 31.

43.

Apathy and higher level of gait control in normal pressure hydrocephalus.

Allali G, Laidet M, Armand S, Saj A, Krack P, Assal F.

Int J Psychophysiol. 2017 Sep;119:127-131. doi: 10.1016/j.ijpsycho.2016.12.002. Epub 2016 Dec 11.

PMID:
27965058
44.

Commentaries on "Subthalamic Deep Brain Stimulation in Obsessive-Compulsive Disorder: First German Experience and Future Outlook".

Chabardes S, Krack P, Polosan M.

World Neurosurg. 2016 Nov;95:609-610. doi: 10.1016/j.wneu.2016.08.037. No abstract available.

PMID:
27923468
45.

Response inhibition rapidly increases single-neuron responses in the subthalamic nucleus of patients with Parkinson's disease.

Benis D, David O, Piallat B, Kibleur A, Goetz L, Bhattacharjee M, Fraix V, Seigneuret E, Krack P, Chabardès S, Bastin J.

Cortex. 2016 Nov;84:111-123. doi: 10.1016/j.cortex.2016.09.006. Epub 2016 Sep 21.

PMID:
27745848
46.

The Pioneering and Unknown Stereotactic Approach of Roeder and Orthner from Göttingen. Part I. Surgical Technique for Tailoring Individualized Stereotactic Lesions.

Hamel W, Köppen JA, Hariz M, Krack P, Moll CK.

Stereotact Funct Neurosurg. 2016;94(4):240-253. Epub 2016 Sep 16. Review.

47.

Long-term improvement in obsessions and compulsions with subthalamic stimulation.

Polosan M, Chabardes S, Bougerol T, Ardouin C, Pollak P, Benabid AL, Krack P.

Neurology. 2016 Oct 25;87(17):1843-1844. Epub 2016 Sep 21. No abstract available.

PMID:
27655738
48.

Statistical Models of Parkinson's Disease Progression: Predictive Validity in a 3-Year Follow-up.

Mendes A, Gonçalves A, Vila-Chã N, Calejo M, Moreira I, Fernandes J, Damásio J, Teixeira-Pinto A, Krack P, Lima AB, Cavaco S.

J Parkinsons Dis. 2016 Oct 19;6(4):793-804.

PMID:
27589537
49.

The prominent role of serotonergic degeneration in apathy, anxiety and depression in de novo Parkinson's disease.

Maillet A, Krack P, Lhommée E, Météreau E, Klinger H, Favre E, Le Bars D, Schmitt E, Bichon A, Pelissier P, Fraix V, Castrioto A, Sgambato-Faure V, Broussolle E, Tremblay L, Thobois S.

Brain. 2016 Sep;139(Pt 9):2486-502. doi: 10.1093/brain/aww162. Epub 2016 Aug 17.

PMID:
27538418
50.

Cost-effectiveness of neurostimulation in Parkinson's disease with early motor complications.

Dams J, Balzer-Geldsetzer M, Siebert U, Deuschl G, Schuepbach WM, Krack P, Timmermann L, Schnitzler A, Reese JP, Dodel R; EARLYSTIM-investigators.

Mov Disord. 2016 Aug;31(8):1183-91. doi: 10.1002/mds.26740.

PMID:
27506638

Supplemental Content

Support Center